about
Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to β2-agonist Treatment.Consensus statement on standard of care for congenital myopathies.Systemic corticosteroids in acute chest syndrome: friend or foe?Lung function in sickle cell disease.Somatic growth and lung function in sickle cell disease.Chest wall abnormalities and their clinical significance in childhood.Pectus deformities and their impact on pulmonary physiology.Changes in lung function in children with sickle cell disease.Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea.Acute Chest Syndrome, Asthma, and Lung Function in Sickle Cell Disease. Which Is the Chicken, and Which Is the Egg?Lung function in sickle cell disease: An elusive relationship.Lung growth and function in children and adolescents with idiopathic pectus excavatum.203rd ENMC international workshop: respiratory pathophysiology in congenital muscle disorders: implications for pro-active care and clinical research 13-15 December, 2013, Naarden, The Netherlands.Controversies in the diagnosis and treatment of sickle cell lung disease.Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.Pulmonary hypertension in Jarcho-Levin syndrome.Lung function in infants after repair of congenital diaphragmatic hernia.Longitudinal changes in lung function and somatic growth in children with sickle cell disease.Contribution of airway hyperresponsiveness to lower airway obstruction after extracorporeal membrane oxygenation for meconium aspiration syndrome.Nonbronchoscopic bronchoalveolar lavage in mechanically ventilated infants: technique, efficacy, and applicationsForced expiratory flow in uninfected infants and children born to HIV-infected mothersLung function in infants with sickle cell diseaseElectrical injuriesLung function and somatic growth in patients with hemoglobin SC sickle cell diseaseChest wall deformities: advances and uncertaintiesOral corticosteroids in children with wheezingHeterogeneity in the Diagnostic Criteria Physicians Use in Pediatric Asthma
P50
Q35157970-5474459C-E2D1-4988-92D3-A7BEDE119509Q37585735-FD7E401C-27E5-453A-80DE-874936747496Q38165525-07C8113A-4B37-411A-8E6F-3557D7465909Q38165526-D6E55E52-8798-4037-BDEB-55D80A27D910Q38165527-8A386880-7D99-444E-91A0-A5CCF7DE2F44Q38181812-D1EA92DF-C7C8-4B5C-8DA3-016BA03F81E8Q38281263-EF2E7B60-AAF1-4FC1-A07B-8F32E932430EQ43637729-37E7820B-0EBE-45C7-BCD0-2DFCED7E3548Q46738958-537FFC28-CD05-4962-AB20-5C15E720D6B7Q47827596-F9297E4D-1C40-4ECE-A7EC-166D1B81E44EQ47876042-E2448884-9D1B-4C56-B604-7681A964AA87Q47934999-891CBEFC-D806-442D-AA29-7C9406A4EB1AQ47999465-1CDA9FE2-F75A-4BDE-B2A2-7193E4B6EE5FQ48137769-D07CACFD-B720-4A74-B5E1-A1825786F6D4Q50615436-7EC4FD7E-59D4-4A3C-A9D3-57B5864E2D41Q51729817-9ED4DD98-F649-4CE1-A7ED-BE0BDDFCC816Q51783301-7E260167-54D5-48EE-B926-DBE6190646AEQ53556429-B961FEB2-2036-4892-9DE3-5BC89CCD091CQ54176376-12EE3613-88AB-49AC-AC61-E29B2AB6A0C0Q70651520-92EF6E60-D0D0-4D25-83D4-5326B3B56DDFQ73702479-C9B07B98-E4CB-4FB0-9702-CE6DE97A4990Q73877393-044AF6D2-612A-4AD1-8ACC-D413337C0FD4Q78797655-43F2115E-BE63-431F-8B2F-9A4E2ACA8DD5Q80214247-5A0C785A-146B-461E-B881-F981E36E4CACQ83318382-09D0DFE8-F9F8-414F-A78F-8E511E006CF9Q83658361-98D982BD-0B77-4B00-BC4D-9E49090236E2Q93372571-7FC9FE51-7D95-40D1-9264-2178DFF44608
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anastassios C Koumbourlis
@ast
Anastassios C Koumbourlis
@en
Anastassios C Koumbourlis
@es
Anastassios C Koumbourlis
@nl
Anastassios C Koumbourlis
@sl
type
label
Anastassios C Koumbourlis
@ast
Anastassios C Koumbourlis
@en
Anastassios C Koumbourlis
@es
Anastassios C Koumbourlis
@nl
Anastassios C Koumbourlis
@sl
altLabel
Tassos Koumbourlis
@en
prefLabel
Anastassios C Koumbourlis
@ast
Anastassios C Koumbourlis
@en
Anastassios C Koumbourlis
@es
Anastassios C Koumbourlis
@nl
Anastassios C Koumbourlis
@sl
P106
P21
P31
P496
0000-0002-4400-4885